From WSJ 3/14/2023

[Larry and Kitties]

Novo, one of the biggest sellers of insulin in the U.S. and around the world, said Tuesday it would cut the list price of its NovoLog insulin by 75% and the prices for Novolin and Levemir by 65% starting in January 2024.


Good for Levemir users.